The initiator, Robin Koops, started to develop the device in 2004 and ran the first tests on himself. In October 2016 Inreda Diabetic B.V. got the ISO 13485 license, a first requirement to produce its artificial pancreas.
The initiator, Robin Koops, began developing the device in 2004 and conducted initial tests on himself. In October 2016, Inreda Diabetic B.V. obtained the ISO 13485 license, a prerequisite for producing its artificial pancreas.